The Latest Breaking News from Pfizer

Companies are working to develop updated Covid boosters. Will they be too late to make a difference for the vaccine stocks — and society?

Moderna Inc. sued Pfizer Inc. and BioNTech SE, claiming the technology in their COVID-19 shot infringes on its patents, a move that sets the stage for a massive legal clash between the vaccine titans.

Pharmaceutical giant Pfizer’s (PFE) omicron-targeted booster doses could soon be authorized this fall. The company has benefited largely from the pandemic and its vaccine rollouts. Now let’s find out if PFE is a Buy now as it prepares to roll out its booster doses….

The lawsuit seeks unspecified monetary damages for patent infringement.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

LOS ANGELES — California schools reopened for the fall semester with loosened COVID-19 protocols and low student vaccination rates among younger children, presenting a new test for the trajectory of the pandemic as some experts expect another rise in cases when winter arrives.